ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
PFB63
|
1.1K |
349K |
14 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
1.1K
|
349K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
PFB63
|
24K |
12M |
34 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
24K
|
12M
|
34
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
PFB63
|
28 |
9.5K |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
28
|
9.5K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
PFB63
|
716 |
203K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
203K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
PFB63
|
1.0K |
399K |
9 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
PFB63
|
1.3K |
554K |
2 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
554K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
PFB63
|
9.9K |
2.9M |
4 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
9.9K
|
2.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
PFB63
|
576 |
205K |
5 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
576
|
205K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
PFB63
|
576 |
205K |
8 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
576
|
205K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
PFB63
|
850 |
252K |
16 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
252K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Update on Clinical Trial of Oncolytic Virotherapy CHECKvacc
|
|
PFB63
|
95 |
55K |
43 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
95
|
55K
|
43
|
|
ASX - By Stock
|
CHN |
Re:
Ann: VMS: CHN completes 1st stage JV on Julimar Lookalike Target
|
|
PFB63
|
11 |
7.8K |
18 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
11
|
7.8K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
FY22 - It's all to play for here!
|
|
PFB63
|
145 |
41K |
8 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
145
|
41K
|
8
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Results from Pulmonary Studies
|
|
PFB63
|
65 |
12K |
0 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
65
|
12K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Results from Pulmonary Studies
|
|
PFB63
|
65 |
12K |
0 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
65
|
12K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Change of Director's Interest Notice
|
|
PFB63
|
10 |
3.3K |
5 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
10
|
3.3K
|
5
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Trading Halt
|
|
PFB63
|
46 |
21K |
3 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
46
|
21K
|
3
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Trading Halt
|
|
PFB63
|
46 |
21K |
5 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
46
|
21K
|
5
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Extensive Ni-Cu Soil Anomalism at Julimar
|
|
PFB63
|
231 |
104K |
0 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
231
|
104K
|
0
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Pause in Trading
|
|
PFB63
|
35 |
10K |
3 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
35
|
10K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
PFB63
|
1.6K |
464K |
11 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
PFB63
|
1.6K |
464K |
29 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
1.6K
|
464K
|
29
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
PFB63
|
533 |
191K |
4 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
533
|
191K
|
4
|
|
ASX - By Stock
|
CHN |
Re:
Ann: VMS:Chalice commences EM program on Julimar lookalike target
|
|
PFB63
|
53 |
22K |
3 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
53
|
22K
|
3
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Becoming a substantial holder
|
|
PFB63
|
96 |
39K |
10 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
96
|
39K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
PFB63
|
508 |
172K |
5 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
172K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
PFB63
|
1.1K |
313K |
16 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
313K
|
16
|
|
ASX - By Stock
|
CHN |
Re:
Chn drilling results
|
|
PFB63
|
90 |
46K |
8 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
90
|
46K
|
8
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Chalice Secures Access to Major New Targets at Julimar
|
|
PFB63
|
59 |
37K |
5 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
59
|
37K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
PFB63
|
796 |
395K |
14 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
395K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
PFB63
|
796 |
395K |
48 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
796
|
395K
|
48
|
|
ASX - By Stock
|
CHN |
Re:
CHN 2021
|
|
PFB63
|
7 |
3.4K |
0 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
7
|
3.4K
|
0
|
|
ASX - By Stock
|
CHN |
Re:
400 Not Out
|
|
PFB63
|
44 |
16K |
0 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
44
|
16K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
PFB63
|
344 |
180K |
1 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
344
|
180K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
PFB63
|
344 |
180K |
20 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
344
|
180K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
PFB63
|
13K |
5.0M |
4 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
13K
|
5.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB - path back to $5?
|
|
PFB63
|
6 |
3.6K |
0 |
19/10/20 |
19/10/20 |
ASX - By Stock
|
6
|
3.6K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
PFB63
|
555 |
268K |
3 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
268K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
PFB63
|
635 |
278K |
4 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
278K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB POST FDA approval
|
|
PFB63
|
80 |
49K |
8 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
80
|
49K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
FDA/PDUFA calendar for Biotech
|
|
PFB63
|
24 |
12K |
2 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
24
|
12K
|
2
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Major New 6.5km-long EM Anomaly Identified at Julimar
|
|
PFB63
|
176 |
87K |
10 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
176
|
87K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial
|
|
PFB63
|
299 |
139K |
1 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
299
|
139K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
What the hell is Convalescent plasma therapy
|
|
PFB63
|
41 |
18K |
3 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
41
|
18K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
5 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
6 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
17 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
15 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
19 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
35 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
35
|
|